pneumococcal conjugate vaccines
Research activity centers on pneumococcal immunization across infants, toddlers, children, and adolescents, with attention to immune responses against multiple serotypes and the comparative performance of 21-valent formulations.
- serotype-specific immunogenicity
- opsonophagocytic activity
- safety and tolerability
- catch-up vaccination
The portfolio includes evaluation of IgG antibody responses and functional antibody activity in pediatric age groups.
meningococcal vaccines
Clinical research includes meningococcal immunization in healthy children, toddlers, and infants, with focus on multivalent coverage for serogroups A, C, W-135, Y, and MenB reference strains.
- pentavalent meningococcal vaccine
- humoral immune response
- pediatric vaccination schedules
- serogroup coverage
Work in this area emphasizes immune responses measured after routine pediatric vaccination time points.
respiratory syncytial virus prevention
The sponsor funds research in virus diseases, especially respiratory syncytial virus prevention in infants and toddlers, with interest in protection against lower respiratory tract disease.
- RSV vaccine
- lower respiratory tract disease
- pediatric viral infection
- immune protection
These studies address both efficacy and safety in early childhood populations.
pediatric immunization across age groups
Across its vaccine programs, the clinical landscape spans healthy infants, preterm infants, toddlers, children, and adolescents, reflecting a strong focus on age-appropriate immunization strategies.
- immune response assessment
- age-specific vaccination
- pediatric safety evaluation
- comparative vaccine immunogenicity
Research sites are distributed internationally across multiple countries, supporting broad pediatric vaccine development.
